$ZYME's ZW191 ... the most promising anti-FRα ADC to date. Given the previous results of ZW33 and ZW49, that wasn't necessarily to be exp...

AACR 2026 现场信号· @ · X·2026-04-22 06:44· 2026-04-22Score60

Body · original

$ZYME's ZW191 ... the most promising anti-FRα ADC to date. Given the previous results of ZW33 and ZW49, that wasn't necessarily to be expected.

#AACR26 Presentation →

https://t.co/IvPsnbSCkD

Heat 15 · 13 likes · 1 reply · 1 repost

Conference abstracts

CT306NCT06555744matched by 代号 ZW191

Phase 1 first-in-human multicenter open-label study of ZW191, a folate receptor α (FRα)-targeting antibody-drug conjugate (ADC), in patients with advanced solid tumors: Part 1 dose-escalation results

Patricia LoRusso, David Sommerhalder, Kosei Hasegawa, Kenichi Harano, David S. Tan, Noboru Yamamoto, David M. O’Malley, Kathleen N. Moore, Sarah E. Church, Lin Lu, Sabeen Mekan, Pranshul Chauha, Jung-Yun Lee

Read the abstract →

Source: AACR 2026 现场信号 · x.com